Latest Whitepapers

Although there are initiatives to de-risk the drug development process, continually applying the same tools and approaches is unlikely to lead to innovative, first- or best-in-class targets and transformative progress.

Developing mRNA-based therapeutics is complex work, requiring highly skilled scientists, high-tech microfluidics platforms and sophisticated analytical equipment, and of course the mRNA itself.

Novice and expert in vitro diagnostics (IVD) manufacturers agree that developing, optimizing, and launching a lateral flow assay (LFA) test is never routine nor easy.

This whitepaper highlights how vendor-qualified, automated library preparation methods can accelerate a variety of NGS workflows.

Amidst the life science industry’s digital transformation, new and established companies have pioneered innovative ways to harness data and technology across the drug development lifecycle.

This whitepaper outlines formulation materials for anode, cathode and electrolyte analysis. It details how to optimize your production needs with customized chemical blends and highlights analytical standard solutions for use in elemental analysis.

This whitepaper highlights specific case studies that reveal how researchers are applying nanopore technology to a variety of sequencing techniques, including whole genome, targeted, RNA sequencing and single-cell analysis.

This whitepaper highlights the recent developments and performance of three modular benchtop solutions for the high-performance quantitation and kinetics characterization of proteins and their small molecule interactions.

This whitepaper highlights the features and capabilities of a novel system for streamlining affinity analysis for rapid lead molecule screening.

Per-and polyfluoroalkyl substances (PFAS) can persist in our environment for longer than any other artificial substance. They’re associated with negative health effects, yet, they are pervasive in our water systems.